Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Trial of Dasatinib in Patients With Metastatic Pancreatic Cancer

NCT00544908 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00544908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00544908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Trial of Dasatinib in Patients With Metastatic Pancreatic Cancer
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2007
Completion date
Not reported
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer